- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunotech Biopharm Ltd (6978)
Immunotech Biopharm Ltd stock price live, this page displays HK 6978 stock exchange data. View the 6978 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immunotech Biopharm Ltd real time stock price chart below.
What Is the Immunotech Biopharm Ltd Stock Price Today?
The Immunotech Biopharm Ltd stock price today is 4.14.
What Is the Stock Symbol for Immunotech Biopharm Ltd?
The stock symbol for Immunotech Biopharm Ltd is ""6978.""
What Stock Exchange Does Immunotech Biopharm Ltd Trade On?
Immunotech Biopharm Ltd is listed and trades on the Hong Kong stock exchange.
Is Immunotech Biopharm Ltd a Good Stock to Buy?
Determining whether Immunotech Biopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6978 quote. (ISIN: KYG4721A1004)
What Is the Immunotech Biopharm Ltd Stock Price Today?
The Immunotech Biopharm Ltd stock price today is 4.14.
What Is the Stock Symbol for Immunotech Biopharm Ltd?
The stock symbol for Immunotech Biopharm Ltd is ""6978.""
What Stock Exchange Does Immunotech Biopharm Ltd Trade On?
Immunotech Biopharm Ltd is listed and trades on the Hong Kong stock exchange.
Is Immunotech Biopharm Ltd a Good Stock to Buy?
Determining whether Immunotech Biopharm Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6978 quote. (ISIN: KYG4721A1004)
Hong Kong
Currency in HKD
4.14
-0.06(-1.43%)
Closed·
Fair Value
An estimate of a Immunotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.08
4.20
52 wk Range
1.50
6.15
6978 Scorecard
Full Analysis
Suffers from weak gross profit margins
6978 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Immunotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.084.20
52 wk Range
1.506.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6978 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Immunotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Immunotech Biopharm Ltd Company Profile
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that is in Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia; RC19D2 for relapsed and refractory diffuse large B-cell lymphoma; and TCR-T cell series products to treat solid tumors. In addition, the company develops pre-clinical products, such as aT19 to treat hematologic malignancies; YT003 and YT008 for post transplantation infections; YT007 for solid tumors; and VAC-aT19 for hematologic malignancies. Immunotech Biopharm Ltd was founded in 2006 and is headquartered in Beijing, the People’s Republic of China.
Compare 6978 to Peers and Sector
Metrics to compare | 6978 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6978PeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.6x | −13.2x | −0.5x | |
PEG Ratio | −0.24 | 0.28 | 0.00 | |
Price/Book | −148.8x | 7.0x | 2.6x | |
Price / LTM Sales | - | 19.1x | 3.3x | |
Upside (Analyst Target) | - | 3.8% | 42.8% | |
Fair Value Upside | Unlock | −13.1% | 6.5% | Unlock |
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
-0.18 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Immunotech Trade On?
Immunotech is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Immunotech?
The stock symbol for Immunotech is "6978."
What Is the Immunotech Market Cap?
As of today, Immunotech market cap is 2.16B.
What Is Immunotech's Earnings Per Share (TTM)?
The Immunotech EPS (TTM) is -0.36.
From a Technical Analysis Perspective, Is 6978 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Immunotech Stock Split?
Immunotech has split 0 times.
How Many Employees Does Immunotech Have?
Immunotech has 154 employees.
What is the current trading status of Immunotech (6978)?
As of 06 Aug 2025, Immunotech (6978) is trading at a price of 4.14, with a previous close of 4.20. The stock has fluctuated within a day range of 4.08 to 4.20, while its 52-week range spans from 1.50 to 6.15.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.